The rs11705701 G>A polymorphism of IGF2BP2 is associated with IGF2BP2 mRNA and protein levels in the visceral adipose tissue - A link to type 2 diabetes susceptibility

Review of Diabetic Studies

Volumn 9, Issue 2-3, 2012, Pages 105-115

  Chistiakov, Dimitry A ^a   Nikitin, Alexey G ^b   Smetanina, Svetlana A ^c   Bel'chikova, Larisa N ^c   Suplotova, Lyudmila A ^c   Shestakova, Marina V ^d   Nosikov, Valery V ^b  

^a PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^b STATE RESEARCH INSTITUTE OF GENETICS AND SELECTION OF INDUSTRIAL MICROORGANISMS   (Russian Federation)

^c TYUMEN STATE MEDICAL UNIVERSITY   (Russian Federation)

^d N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

Author keywords

Adipose tissue; Insulin resistance; Insulin like growth factor 2; Isoform; Polymorphism; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ISOPROTEIN; MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 2; IGF2BP2 PROTEIN, HUMAN; RNA; RNA BINDING PROTEIN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; WESTERN BLOTTING; BIOPSY; CHEMISTRY; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; REGRESSION ANALYSIS; RUSSIAN FEDERATION;

BIOPSY; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; RNA; RNA-BINDING PROTEINS; RUSSIA;

EID: 84881282853     PISSN: 16136071     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/rds.2012.9.112     Document Type: Article

References (54)

1. Nielsen J, Christiansen J, Lykke-Andersen J, Johnsen AH, Wewer UM, Nielsen FC. A family of insulin like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol 1999. 19:1262-1270.
2. Nielsen FC, Nielsen J, Kristensen MA, Koch G, Christiansen J. Cytoplasmic trafficking of IGF-II mRNA-binding protein by conserved KH domains. J Cell Sci 2002. 115:2087-2097.
3. Nielsen J, Adolph SK, Rajpert-De Meyts E, Lykke-Andersen J, Koch G, Christiansen J, Nielsen FC. Nuclear transit of human zipcode-binding protein IMP1. Biochem J 2003. 376:383-391.
4. Jonson L, Vikesaa J, Krogh A, Nielsen LK, Hansen T, Borup R, Johnsen AH, Christiansen J, Nielsen FC. Molecular composition of IMP1 ribonucleoprotein granules. Mol Cell Proteomics 2007.6:798-811.
5. Keene JD, Tenenbaum SA. Eukaryotic mRNPs may represent posttranscriptional operons. Mol Cell 2002. 9:1161-1167.
6. Dai N, Rapley J, Angel M, Yanik MF, Blower MD, Avruch J. mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry. Genes Dev 2007. 25:1159-1172.
7. Wagner M, Kunsch S, Duerschmied D, Beil M, Adler G, Mueller F, Gress TM. Transgenic overexpression of the oncofetal RNA binding protein KOC leads to remodeling of the exocrine pancreas. Gastroenterology 2003. 124:1901-1914.
8. Spagnoli FM, Brivanlou AH. The RNA-binding protein, Vg1RBP, is required for pancreatic fate specification. Dev Biol 2006. 292:442-456.
9. Wellcome Trust Case Control Consortium. Genomewide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007. 447:661-678.
10. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, Roix JJ, Kathiresan S, Hirschhorn JN, Daly MJ, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007. 316:1331-1336.
11. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, Erdos MR, Stringham HM, Chines PS, Jackson AU, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007. 316:1341-1345.
12. Grarup N, Rose CS, Andersson EA, Andersen G, Nielsen AL, Albrechtsen A, Clausen JO, Rasmussen SS, Jorgensen T, Sandbaek A, et al. Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association 309 studies. Diabetes 2007. 56:3105-3111.
13. Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, Tuomi T, Berglund G, Altshuler D, Nilsson P, Groop L. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 2008. 359:2220-2232.
14. Hertel JK, Johansson S, Raeder H, Midthjell K, Lyssenko V, Groop L, Molven A, Njolstad PR. Genetic analysis of recently identified type 2 diabetes loci in 1,638 unselected patients with type 2 diabetes and 1,858 control participants from a Norwegian population-based cohort (the HUNT study). Diabetologia 2008. 51:971-977.
15. Omori S, Tanaka Y, Takahashi A, Hirose H, Kashiwagi A, Kaku K, Kawamori R, Nakamura Y, Maeda S. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes 2008. 57:791-795.
16. Horikawa Y, Miyake K, Yasuda K, Enya M, Hirota Y, Yamagata K, Hinokio Y, Oka Y, Iwasaki N, Iwamoto Y, et al. Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. J Clin Endocrinol Metab 2008. 93:3136-3141.
17. Ng MC, Park KS, Oh B, Tam CH, Cho YM, Shin HD, Lam VK, Ma RC, So WY, Cho YS, et al. Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians. Diabetes 2008. 57:2226-2233.
18. Hu C, Zhang R, Wang C, Wang J, Ma X, Lu J, Qin W, Hou X, Wang C, Bao Y, Xiang K, et al. PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population. PLoS One 2009. 4:e7643.
19. Chauhan G, Spurgeon CJ, Tabassum R, Bhaskar S, Kulkarni SR, Mahajan A, Chavali S, Kumar MV, Prakash S, Dwivedi OP, et al. Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the risk of type 2 diabetes in 5,164 Indians. Diabetes 2010. 59:2068-2074.
20. Jia H, Yu L, Jiang Z, Ji Q. Association between IGF2BP2 rs4402960 polymorphism and risk of type 2 diabetes mellitus: a meta-analysis. Arch Med Res 2011. 42:361-367.
21. Zhao Y, Ma YS, Fang Y, Liu L, Wu SD, Fu D, Wang XF. IGF2BP2 genetic variation and type 2 diabetes: a global meta-analysis. DNA Cell Biol 2012. 31:713-720.
22. Groenewoud MJ, Dekker JM, Fritsche A, Reiling E, Nijpels G, Heine RJ, Maassen JA, Machicao F, Schäfer SA, Häring HU, et al. Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps. Diabetologia 2008. 51:1659-1663.
23. Wu Y, Li H, Loos RJ, Yu Z, Ye X, Chen L, Pan A, Hu FB, Lin X. Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes 2008. 57:2834-2842.
24. Stancakova A, Kuulasmaa T, Paananen J, Jackson AU, Bonnycastle LL, Collins FS, Boehnke M, Kuusisto J, Laakso M. Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men. Diabetes 2009. 58:2129-2136.
25. Rodriguez S, Eiriksdottir G, Gaunt TR, Harris TB, Launer LJ, Gudnason V, Day IN. IGF2BP1, IGF2BP2 and IGF2BP3 genotype, haplotype and genetic model studies in metabolic syndrome traits and diabetes. Growth Horm IGF Res 2010. 20:310-318.
26. Ruchat SM, Elks CE, Loos RJ, Vohl MC, Weisnagel SJ, Rankinen T, Bouchard C, Perusse L. Evidence of interaction between type 2 diabetes susceptibility genes and dietary fat intake for adiposity and glucose homeostasisrelated phenotypes. J Nutrigenet Nutrigenomics 2009. 2:225-234.
27. Li X, Allayee H, Xiang AH, Trigo E, Hartiala J, Lawrence JM, Buchanan TA, Watanabe RM. Variation in IGF2BP2 interacts with adiposity to alter insulin sensitivity in Mexican Americans. Obesity (Silver Spring) 2009. 17:729-736.
28. Christiansen J, Kolte AM, Hansen TO, Nielsen FC. IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes. J Mol Endocrinol 2009. 43:187-195.
29. Le HT, Sorrell AM, Siddle K. Two isoforms of the mRNA binding protein IGF2BP2 are generated by alternative translational initiation. PLoS One 2012. 7:e33140.
30. Prokunina-Olsson L, Hanisch JJ, Jackson AU. A novel variant of IGF2BP2 is associated with type 2 diabetes and affects expression of a functional splicing isoform. Diabetes 2008. 57(Suppl 1):A61.
31. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011. 34:S62-S69.
32. International Expert Committee. International Expert Committee report on the rtole of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009. 32:1327-1334.
33. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999. 16:442-443.
34. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985. 28:412-419.
35. Protocol for isolation human adipocytes (adult). Available at http://www.serva.de/servaWeb/www_root/documents/Prot_adipocytes_adult_human.pdf.
36. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Methods 2001. 25:402-408.
37. Ranade K, Chang MS, Ting CT, Pei D, Hsiao CF, Olivier M, Pesich R, Hebert J, Chen YD, Dzau VJ, et al. High-throughput genotyping with single nucleotide polymorphisms. Genome Res 2001. 11:1262-1268.
38. Rusinov V, Baev V, Minkov IN, Tabler M. MicroInspector: a web tool for detection of miRNA binding sites in an RNA sequence. Nucleic Acids Res 2005. 33:W696-W700.
39. Zhou JH. 2LD, GENECOUNTING and HAP: computer programs for linkage disequilibrium analysis. Nucleic Acids Res 2004. 20:1325-1326.
40. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007. 445:881-885.
41. Duesing K, Fatemifar G, Charpentier G, Marre M, Tichet J, Hercberg S, Balkau B, Froguel P, Gibson F. Evaluation of the association of IGF2BP2 variants with type 2 diabetes in French Caucasians. Diabetes 2008. 57:1992-1996.
42. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T, Walters GB, Styrkarsdottir U, Gretarsdottir S, Emilsson V, Ghosh S, et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 2007. 39:770-775.
43. Moore AF, Jablonski KA, McAteer JB, Saxena R, Pollin TI, Franks PW, Hanson RL, Shuldiner AR, Knowler WC, Altshuler D, et al. Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program. Diabetes 2008. 57:2503-2510.
44. Parikh H, Lyssenko V, Groop LC. Prioritizing genes for follow-up from genome wide association studies using information on gene expression in tissues relevant for type 2 diabetes mellitus. BMC Med Genomics 2009. 2:72.
45. Cotsapas C, Prokunina-Olsson L, Welch C, Saxena R, Weaver C, Usher N, Guiducci C, Bonakdar S, Turner N, LaCroix B, et al. Expression analysis of loci associated with type 2 diabetes in human tissues. Diabetologia 2010. 53:2334-2339.
46. Marselli L, Thorne J, Dahiya S, Sgroi DC, Sharma A, Bonner-Weir S, Marchetti P, Weir GC. Gene expression profiles of beta-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes. PLoS One 2010. 5:e11499.
47. Jin LS, Hao XF, Peng BL, Zhang YC, Wan YL, Ji F, Xia JL, Liu XM. Differential expression of six obesityrelated genes with different disease phases of T2DM in cynomolgus monkey. Dongwuxue Yanjiu 2011. 32(1):50-55.
48. Louveau I, Gondret F. Regulation of development and metabolism of adipose tissue by growth hormone and the insulin-like growth factor system. Domest Anim Endocrinol 2004. 27:241-255.
49. Mirales F, Portha B. Early development of beta-cells is impaired in the GK rat model of type 2 diabetes. Diabetes 2001. 50(Suppl 1):S84-S88.
50. Calderari S, Gangnerau MN, Thibault M, Meile MJ, Kassis N, Alvarez C, Portha B, Serradas P. Defective IGF2 and IGF1R protein production in embryonic pancreas precedes beta cell mass anomaly in the Goto-Kakizaki rat model of type 2 diabetes. Diabetologia 2007. 50:1463-1471.
51. Freathy RM, Bennett AJ, Ring SM, Shields B, Groves CJ, Timpson NJ, Weedon MN, Zeggini E, Lindgren CM, Lango H, et al. Type 2 diabetes risk alleles are associated with reduced size at birth. Diabetes 2009. 58:1428-1433.
52. van Hoek M, Langendonk JG, de Rooij SR, Sijbrands EJ, Roseboom TJ. Genetic variant in the IGF2BP2 gene may interact with fetal malnutrition to affect glucose metabolism. Diabetes 2009. 58:1440-1444.
53. Meier JJ. Linking the genetics of type 2 diabetes with low birth weight: A role for prenatal islet maldevelopment. Diabetes 2009. 58:1255-1256.
54. Maris C, Dominguez C, Allain FH. The RNA recognition motif, a plastic RNA-binding platform to regulate posttranscriptional gene expression. FEBS J 2005. 272: 2118-2131.